hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol.67 No.3 Rujan 2017.

Kratko priopćenje
https://doi.org/10.1515/acph-2017-0030

Influence of novel oral anticoagulants on anticoagulation care management

ANDREJ JANZIC   ORCID icon orcid.org/0000-0003-0562-3875 ; University of Ljubljana, Faculty of Pharmacy, 1000 Ljubljana, Slovenia
MITJA KOS ; University of Ljubljana, Faculty of Pharmacy, 1000 Ljubljana, Slovenia

Puni tekst: engleski, pdf (467 KB) str. 397-406 preuzimanja: 52* citiraj
APA
JANZIC, A., KOS, M. (2017). Influence of novel oral anticoagulants on anticoagulation care management. Acta Pharmaceutica, 67(3). doi:10.1515/acph-2017-0030

Sažetak
Anticoagulation treatment was recently improved by the introduction of novel oral anticoagulants (NOACs). Using a combination of qualitative and quantitative methods, this study explores the effects of the introduction of NOACs on anticoagulation care in Slovenia. Face-to-face interviews with key stakeholders revealed evolvement and challenges of anticoagulation care from different perspectives. Obtained information was further explored through the analysis of nationwide data of drug prescriptions and realization of health care services. Simplified management of anticoagulation treatment with NOACs and their high penetration expanded the capacity of anticoagulation clinics, and consequentially the treated population increased by more than 50 % in the last 5 years. The main challenge concerned the expenditures for medicines, which increased approximately 10 times in just a few years. At the same time, the anticoagulation clinics and their core organisation were not affected, which is not expected to change, since they are vital in delivering high-quality care.

Ključne riječi
novel oral anticoagulants; health care management; anticoagulation care

Hrčak ID: 183018

URI
http://hrcak.srce.hr/183018

Posjeta: 105 *